Inhibition of seminal emission Is the main cause of anejaculation induced by a new highly selective α1A-Blocker in normal volunteers

Journal of Sexual Medicine

Volumn 5, Issue 9, 2008, Pages 2185-2190

  Kobayashi, Ko ^a   Masumori, Naoya ^a   Hisasue, Shin Ichi ^a   Kato, Ryuichi ^a   Hashimoto, Kohei ^a   Itoh, Naoki ^a   Tsukamoto, Taiji ^a  

^a SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Alpha Blocker; Anejaculation; Ejaculation; Emission; Prostatic hyperplasia

Indexed keywords

FRUCTOSE; PLACEBO; SILODOSIN;

ADULT; ANEJACULATION; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG SELECTIVITY; EJACULATION; EJACULATION DISORDER; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SEMEN ANALYSIS; SEMINAL PLASMA; SPERMATOZOON COUNT; SPERMATOZOON DENSITY;

EID: 51349132022     PISSN: 17436095     EISSN: 17436109     Source Type: Journal    
DOI: 10.1111/j.1743-6109.2008.00779.x     Document Type: Article

References (35)

1. AUA Practice Guidelines Committee. AUA guideline on management of benign prostatic hyperplasia (2003). Chapter 1: Diagnosis and treatment recommendations. J Urol 2003;170:530-47.
2. Lepor H, Tang R, Meretyk S, Shapiro E. Alpha 1 adrenoceptor subtypes in the human prostate. J Urol 1993;149:640-2.
3. Roehrborn CG, Schwinn DA. Alpha1-adrenergic receptors and their inhibitors in lower urinary tract symptoms and benign prostatic hyperplasia. J Urol 2004;171:1029-35.
4. Kawabe K, Yoshida M, Homma Y. Silodosin, a new alpha1A-adrenoceptor-selective antagonist for treating benign prostatic hyperplasia: Results of a phase III randomized, placebo-controlled, double-blind study in Japanese men. BJU Int 2006;98:1019-24.
5. Sadeghi-Nejad H, Jackson I. New-onset priapism associated with ingestion of terazosin in an otherwise healthy man. J Sex Med 2007;4:1766-8.
6. Tarhan F, Canguven O, Kuyumcuoglu U. Intracavernous sodium nitroprusside (SNP) versus papaverine/phentolamine in erectile dysfunction: A comparative study of short-term efficacy and side-effects. J Sex Med 2006;3:377.
7. Shamloul R, El-Dakhly M, Ghanem H, Gadallah A, Mokhtar H. Intracavernous chlorpromazine versus phentolamine: A double-blind clinical comparative study. J Sex Med 2004;1;310-3.
8. Chew KK. Combination pharmacotherapy in the management of patients with hard-to-treat erectile dysfunction. J Sex Med 2006;3:185-7.
9. Shabsigh R. Diagnosing premature ejaculation: A review. J Sex Med 2006;3(4suppl):318-23.
10. Sharlip ID. Guidelines for the diagnosis and management of premature ejaculation. J Sex Med 2006;3(4suppl):309-17.
11. Broderick GA. Premature ejaculation: On defining and quantifying a common male sexual dysfunction. J Sex Med 2006;3(4suppl):295-302.
12. Broderick GA. Premature ejaculation. J Sex Med 2006;3(4suppl):293-4.
13. Shindel A, Nelson C, Brandes S. Urologist practice patterns in the management of premature ejaculation: A nationwide survey. J Sex Med 2008;5:954-64.
14. Jern P, Santtila P, Witting K, Alanko K, Harlaar N, Johansson A, von der Pahlen B, Varjonen M, Vikström N, Algars M, Sandnabba K. Premature and delayed ejaculation: Genetic and environmental effects in a population-based sample of Finnish twins. J Sex Med 2007;4;1739-49.
15. Dhikav V, Karmarkar G, Gupta M, Anand KS. Yoga in premature ejaculation: A comparative trial with fluoxetine. J Sex Med 2007;4:1726-32.
16. Frewen A, Rapee RM, Bowden P, Lagios K. Regional differences in men attending a sexual health clinic in sydney for premature ejaculation. J Sex Med 2007;4:1733-8.
17. Michetti PM, Rossi R, Bonanno D, De Dominicis C, Iori F, Simonelli C. Dysregulation of emotions and premature ejaculation (PE): Alexithymia in 100 outpatients. J Sex Med 2007;4:1462-7.
18. Rowland D, Burek M. Trends in research on premature ejaculation over the past 25 years. J Sex Med 2007;4:1454-61.
19. Patrick DL, Rowland D, Rothman M. Interrelationships among measures of premature ejaculation: The central role of perceived control. J Sex Med 2007;4:780-8.
20. Perelman MA. A new combination treatment for premature ejaculation: A sex therapist's perspective. J Sex Med 2006;3:1004-12.
21. Hisasue S, Furuya R, Itoh N, Kobayashi K, Furuya S, Tsukamoto T. Ejaculatory disorder caused by alpha-1 adrenoceptor antagonists is not retrograde ejaculation but a loss of seminal emission. Int J Urol 2006;13:1311-6.
22. Hellstrom WJ, Sikka SC. Effects of acute treatment with tamsulosin versus alfuzosin on ejaculatory function in normal volunteers. J Urol 2006;176:1529-33.
23. Shibata K, Foglar R, Horie K, Obika K, Sakamoto A, Ogawa S, Tsujimoto G. KMD-3213, a novel, potent, alpha 1a-adrenoceptor-selective antagonist: Characterization using recombinant human alpha 1-adrenoceptors and native tissues. Mol Pharmacol 1995;48;250-8.
24. World Health Organization, WHO laboratory manual for the examination of human semen and sperm-cervical mucus interaction. 4th edition. Cambridge: Cambridge University Press; 1999.
25. Rowe PJ, Camhaire FH, Hargreave TB, Mahmoud AMA. WHO manual for the standardized investigation, diagnosis and management of the infertile male. Cambridge: Cambridge University Press; 2000.
26. Kuhara T. Gas chromatographic-mass spectrometric urinary metabolome analysis to study mutations of inborn errors of metabolism. Mass Spectrom Rev 2005;24:814-27.
27. Steers WD, Andersson KE. Neuroanatomy and physiology of the prostate. In: Lepor H, ed. Prostatic diseases. Philadelphia, PA: W.B. Saunders Company; 2000:28-40.
28. Donatucci CF. Etiology of ejaculation and pathophysiology of premature ejaculation. J Sex Med 2006;3(4suppl):303-8.
29. Hellstrom WJ. Current and future pharmacotherapies of premature ejaculation. J Sex Med 2006;3(4suppl):332-41.
30. de Jong TR, Veening JG, Olivier B, Waldinger MD. Oxytocin involvement in SSRI-induced delayed ejaculation: A review of animal studies. J Sex Med 2007;4:14-28.
31. Andersson KE, Wyllie MG. Ejaculatory dysfunction: Why all alpha-blockers are not equal. BJU Int 2003;92:876-7.
32. Muto S, Kasahara H, Yokoi R, Hayashi M, Souma S, Kobayashi K, Tamura T, Murakami M, Kuroda J, Shibata N. (KMD-3213) [Toxicity profile of silodosin (KMD-3213)]. Yakugaku Zasshi 2006;126Specno.:247-56.
33. Matsubara Y, Kanazawa T, Kojima Y, Abe Y, Kobayashi K, Kanbe H, Harada H, Momose Y, Terakado S, Adachi Y, Midgley I. (KMD-3213) [Pharmacokinetics and disposition of silodosin (KMD-3213)]. Yakugaku Zasshi 2006;126Specno.:237-45.
34. Overstreet JW, Brazil C. Semen analysis. In: Lipshultz LI, Howards SS, eds. Infertility in the male. 3rd edition. St. Louis, MO: Mosby; 1997:487-90.
35. Oldereid NB, Gordeladze JO, Kirkhus B, Purvis K. Human sperm characteristics during frequent ejaculation. J Reprod Fertil 1984;71:135-40.